XBIT earnings: real EPS beat/miss history, analyst consensus Buy, P/E -1.72. Updated 2026-07-23.
XBiotech (XBIT) Research Hub
XBiotech (XBIT) trades on NASDAQ, US in the Healthcare (Biotechnology) sector. As of 2026-09-11, shares last closed at 2.19 USD (+0.46%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E -1.72, market cap 0.07B. This hub links to the full technical, earnings and options research available for XBIT.
Last updated 2026-09-11 · Source: FMP end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Biotechnology) |
|---|---|
| Exchange | NASDAQ, US |
| Last close | 2.19 USD (+0.46%) |
| 52-week range | 2.15 USD – 2.47 USD |
| Trend regime | Range |
| 14-day RSI | 35.7 (Bearish) |
| Trailing P/E | -1.72 |
| Market cap | 0.07B |
| Dividend yield | 0.00% |
Available research for XBIT
Covered Call on XBIT: how it works, illustrative setup around the real 2.19 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on XBIT: how it works, illustrative setup around the real 2.19 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on XBIT: how it works, illustrative setup around the real 2.19 USD price, max profit/loss, breakeven and when to use it. Educational.
XBIT technical analysis: range, last 2.19 USD, RSI 35.7, 52w range 2.15 USD–2.47 USD, real support/resistance. Updated 2026-09-11.
Frequently asked questions
What sector is XBIT in?
XBiotech (XBIT) is classified under Healthcare (Biotechnology), listed on NASDAQ, US.
Is XBIT in an uptrend or downtrend?
As of 2026-09-11, XBIT is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is XBIT's trailing P/E ratio?
XBIT's trailing P/E is -1.72, with a market cap of 0.07B. See the earnings research page for full valuation detail.